Operating capacity reaches 1.6 billion units, with 10 BFS machines and 4 automated packaging lines.
The Ritedose Corporation becomes EU Compliant, and the quality development lab is expanded.
The Ritedose Corporation launches Ritedose Pharmaceuticals.
Ritedose begins development of a number of ophthalmic products for third-party manufacturing customers.
Olympus acquires Holopack International and changes the name to The Ritedose Corporation.
Operating capacity reaches 700 million units with 6 BFS machines.
RiteDose launch into U.S. pharmaceutical market.
Integration of fully automated packaging line.
Completes design and submits patent application for the RiteDose and SL-Lock.
Receives approval to manufacture schedule II controlled substances.